Moneycontrol PRO
Upcoming Webinar:Prashant Shah explains ‘Irrelevance of Bull & Bear Markets for Success in Technical Analysis’. Register For Free!
you are here: HomeNewsBusiness

IPCA Q4 PAT seen up 126.5% YoY to Rs. 194.8 cr: Sharekhan

Net Sales are expected to increase by 21.1 percent Y-o-Y (down 7.8 percent Q-o-Q) to Rs. 1,300 crore, according to Sharekhan.

April 12, 2021 / 08:13 PM IST
_pharmaceuticals_190_67040683

_pharmaceuticals_190_67040683

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Sharekhan has come out with its fourth quarter (January-March’ 21) earnings estimates for the Pharmaceuticals sector. The brokerage house expects IPCA to report net profit at Rs. 194.8 crore up 126.5% year-on-year (down 27.3% quarter-on-quarter).


Net Sales are expected to increase by 21.1 percent Y-o-Y (down 7.8 percent Q-o-Q) to Rs. 1,300 crore, according to Sharekhan.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Broker Research

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark